Heritage Cannabis (CSE:CANN) CEO Clint Sharples sat down with Steve Darling in the Vancouver studio of Proactive Investors to talk about Heritage buying 30 percent of Endocanna. That company has developed an endocannabinoid DNA test. Sharples talks about why the company made the move and how this has the potential to fuel growth around the world.
0 Comments